Alpha-1 Anti-trypsin Exerts a Hepatoprotective Effect on Immune-mediated Hepatitis and Acetaminophen-induced Liver Injury

The serine proteinase inhibitor alpha-1 anti-trypsin (AAT) protects the body against protease activity. Several functions of AAT beyond those attributed to its anti-protease activity have been described, among them immunomodulatory and anti-inflammatory properties. The present study aimed to determi...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical and translational hepatology Vol. 6; no. 4; pp. 345 - 349
Main Authors Shabat, Yehudit, Ya'acov, Ami Ben, Ilan, Yaron
Format Journal Article
LanguageEnglish
Published China Gastroenterology and Liver Units, Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel 28.12.2018
XIA & HE Publishing Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The serine proteinase inhibitor alpha-1 anti-trypsin (AAT) protects the body against protease activity. Several functions of AAT beyond those attributed to its anti-protease activity have been described, among them immunomodulatory and anti-inflammatory properties. The present study aimed to determine the efficacy of AAT for the treatment of immune-mediated liver injury using the models of concanavalin A-induced immune-mediated hepatitis and acetaminophen -induced liver damage. AAT was administered to mice subjected to concanavalin A-induced immune-mediated hepatitis or 2 h after acetaminophen-induced liver damage. Mice were followed for changes in serum levels of liver enzymes, liver histology, and for interferon gamma serum levels. Treatment with AAT alleviated concanavalin A-induced immune-mediated liver damage, as demonstrated by a reduction in the serum levels of liver enzymes and interferon gamma, and an improved lymphocyte infiltration into the liver on liver biopsies. Moreover, treatment with AAT was associated with alleviation of the acetaminophen-induced liver injury. AAT exerts an hepatoprotective effect on immune-mediated and drug-induced liver damage. The data support its potential use in patients with immune-associated liver disorders.
AbstractList The serine proteinase inhibitor alpha-1 anti-trypsin (AAT) protects the body against protease activity. Several functions of AAT beyond those attributed to its anti-protease activity have been described, among them immunomodulatory and anti-inflammatory properties. The present study aimed to determine the efficacy of AAT for the treatment of immune-mediated liver injury using the models of concanavalin A-induced immune-mediated hepatitis and acetaminophen -induced liver damage. AAT was administered to mice subjected to concanavalin A-induced immune-mediated hepatitis or 2 h after acetaminophen-induced liver damage. Mice were followed for changes in serum levels of liver enzymes, liver histology, and for interferon gamma serum levels. Treatment with AAT alleviated concanavalin A-induced immune-mediated liver damage, as demonstrated by a reduction in the serum levels of liver enzymes and interferon gamma, and an improved lymphocyte infiltration into the liver on liver biopsies. Moreover, treatment with AAT was associated with alleviation of the acetaminophen-induced liver injury. AAT exerts an hepatoprotective effect on immune-mediated and drug-induced liver damage. The data support its potential use in patients with immune-associated liver disorders.
Background and Aims:The serine proteinase inhibitor alpha-1 anti-trypsin (AAT) protects the body against protease activity.Several functions of AAT beyond those attributed to its antiprotease activity have been described,among them immunomodulatory and anti-inflammatory properties.The present study aimed to determine the efficacy of AAT for the treatment of immune-mediated liver injury using the models of concanavalin A-induced immune-mediated hepatitis and acetaminophen -induced liver damage.Methods:AATwas administered to mice subjected to concanavalin A-induced immune-mediated hepatitis or 2 h after acetaminophen-induced liver damage.Mice were followed for changes in serum levels of liver enzymes,liver histology,and for interferon gamma serum levels.Results:Treatment with AATalleviated concanavalin A-induced immunemediated liver damage,as demonstrated by a reduction in the serum levels of liver enzymes and interferon gamma,and an improved lymphocyte infiltration into the liver on liver biopsies.Moreover,treatment with AAT was associated with alleviation of the acetaminophen-induced liver injury.Conclusions:AAT exerts an hepatoprotective effect on immune-mediated and drug-induced liver damage.The data support its potential use in patients with immune-associated liver disorders.
Background and Aims: The serine proteinase inhibitor alpha-1 anti-trypsin (AAT) protects the body against protease activity. Several functions of AAT beyond those attributed to its anti-protease activity have been described, among them immunomodulatory and anti-inflammatory properties. The present study aimed to determine the efficacy of AAT for the treatment of immune-mediated liver injury using the models of concanavalin A-induced immune-mediated hepatitis and acetaminophen -induced liver damage. Methods: AAT was administered to mice subjected to concanavalin A-induced immune-mediated hepatitis or 2 h after acetaminophen-induced liver damage. Mice were followed for changes in serum levels of liver enzymes, liver histology, and for interferon gamma serum levels. Results: Treatment with AAT alleviated concanavalin A-induced immune-mediated liver damage, as demonstrated by a reduction in the serum levels of liver enzymes and interferon gamma, and an improved lymphocyte infiltration into the liver on liver biopsies. Moreover, treatment with AAT was associated with alleviation of the acetaminophen-induced liver injury. Conclusions: AAT exerts an hepatoprotective effect on immune-mediated and drug-induced liver damage. The data support its potential use in patients with immune-associated liver disorders.
Author Ya'acov, Ami Ben
Shabat, Yehudit
Ilan, Yaron
AuthorAffiliation Gastroenterology and Liver Units, Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel
AuthorAffiliation_xml – name: Gastroenterology and Liver Units, Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel
Author_xml – sequence: 1
  givenname: Yehudit
  surname: Shabat
  fullname: Shabat, Yehudit
  organization: Gastroenterology and Liver Units, Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel
– sequence: 2
  givenname: Ami Ben
  surname: Ya'acov
  fullname: Ya'acov, Ami Ben
  organization: Gastroenterology and Liver Units, Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel
– sequence: 3
  givenname: Yaron
  surname: Ilan
  fullname: Ilan, Yaron
  organization: Gastroenterology and Liver Units, Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30637210$$D View this record in MEDLINE/PubMed
BookMark eNpVkUtvEzEUhS1UREvpnhWaJQsm-DEPe4MURYEERWJT1pbHcydxNGMPtqdl8utxmlLBylfyd47P9XmLrqyzgNB7ghekoIR__r663ywoJnyBMWb4FbqhjOCccyKu0kxpmeOaiGt0F8IxIaQkuBL4DbpmuGI1JfgGzct-PKicZEsbTR79PAZjs_Vv8DFkKtvAqKIbvYugo3mAbN11acqczbbDMFnIB2iNitBeUBNNktk2W2qIajDWjQewubHtpBOzSxY-29rj5Od36HWn-gB3z-ct-vl1fb_a5Lsf37ar5S7XBWMxL7Gqoay1IJ0SLSWs5KVSwAtRNKxVteJNW3MsukI3HRYCKNaqbTmuoIauJOwWfbn4jlOTwmqw0atejt4Mys_SKSP_v7HmIPfuQVaM8pqVyeDTxeBR2U7ZvTy6ydsUWfZ6Ph32zekk4VwDLtIfJ_zj83ve_ZogRDmYoKHvlQU3BUlJLVhFGaUJxRdUexeCh-4lFcHyqWN57liezeVTx0ny4d9tXgR_G2V_AEQLplA
CitedBy_id crossref_primary_10_11603_mcch_2410_681X_2019_v_i4_10845
crossref_primary_10_1016_j_cellimm_2020_104157
Cites_doi 10.1073/pnas.0807627105
10.1007/s00296-013-2745-9
10.1007/s00005-012-0162-5
10.1371/journal.pone.0033254
10.1586/ers.11.20
10.1016/j.jhep.2013.03.033
10.1002/path.1869
10.3389/fimmu.2014.00177
10.1016/j.jhep.2015.04.016
10.1007/s11894-999-0086-3
10.1111/j.1365-2249.1992.tb06484.x
10.2174/156652412801318755
10.1111/j.1464-5491.2008.02584.x
10.1097/MCG.0b013e31827873dc
10.1093/rheumatology/ker123
10.2174/0929867321666140916122628
10.4161/auto.4906
10.2119/molmed.2011.00145
10.1038/nrgastro.2013.149
10.1016/j.cld.2007.06.006
10.1002/hep.27024
10.1111/imm.12149
10.1007/s10875-015-0160-6
10.1189/jlb.72.2.262
10.4049/jimmunol.1101340
10.1097/ACI.0000000000000070
10.3389/fimmu.2013.00320
10.1007/s11892-009-0018-5
10.1111/cei.12476
10.1073/pnas.1117665109
10.1371/journal.pone.0177279
10.1007/s11239-007-0088-7
10.3748/wjg.v21.i24.7443
10.1152/ajpgi.00105.2005
10.1093/infdis/jiu620
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
2018 Authors. 2018
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
– notice: 2018 Authors. 2018
DBID NPM
AAYXX
CITATION
7X8
2B.
4A8
92I
93N
PSX
TCJ
5PM
DOI 10.14218/JCTH.2018.00030
DatabaseName PubMed
CrossRef
MEDLINE - Academic
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList PubMed


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Shabat Y. et al: Alpha-1 anti-trypsin is hepatoprotective
EISSN 2310-8819
EndPage 349
ExternalDocumentID lcyzhgbzz_e201804001
10_14218_JCTH_2018_00030
30637210
Genre Journal Article
GrantInformation_xml – fundername: This work was supported in part by the Roaman-Epstein Research Foundation
GroupedDBID 4.4
92I
93N
ADRAZ
ALMA_UNASSIGNED_HOLDINGS
DIK
EBS
EJD
FRP
HYE
KQ8
M48
MET
M~E
NPM
OK1
PGMZT
RPM
TCJ
TGQ
WFFXF
AAYXX
CITATION
7X8
2B.
4A8
92F
PSX
5PM
ID FETCH-LOGICAL-c433t-50a7e57c91fa9d213585aae8494b3da7a8bd7809f4cbf099e20cadd806e7ef513
IEDL.DBID RPM
ISSN 2225-0719
IngestDate Tue Sep 17 21:16:34 EDT 2024
Wed Nov 06 04:25:26 EST 2024
Fri Aug 16 08:28:37 EDT 2024
Fri Aug 23 04:41:42 EDT 2024
Sat Sep 28 08:33:28 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 4
Keywords Alpha-1 anti-trypsin
Drug-induced liver injury
Chronic liver disease
Acetaminophen
Druginduced liver injury
Language English
License This article has been published under the terms of Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0), which permits noncommercial unrestricted use, distribution, and reproduction in any medium, provided that the following statement is provided. “This article has been published in Journal of Clinical and Translational Hepatology at DOI: 10.14218/JCTH.2018.00030 and can also be viewed on the Journal’s website at http://www.jcthnet.com”.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c433t-50a7e57c91fa9d213585aae8494b3da7a8bd7809f4cbf099e20cadd806e7ef513
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Designed the study (YI, ABY), wrote the manuscript (YI, ABY, YS), conducted the experiments (ABY).
The authors have no conflict of interests related to this publication.
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328735/
PMID 30637210
PQID 2179362322
PQPubID 23479
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6328735
wanfang_journals_lcyzhgbzz_e201804001
proquest_miscellaneous_2179362322
crossref_primary_10_14218_JCTH_2018_00030
pubmed_primary_30637210
PublicationCentury 2000
PublicationDate 2018-Dec-28
PublicationDateYYYYMMDD 2018-12-28
PublicationDate_xml – month: 12
  year: 2018
  text: 2018-Dec-28
  day: 28
PublicationDecade 2010
PublicationPlace China
PublicationPlace_xml – name: China
PublicationTitle Journal of clinical and translational hepatology
PublicationTitleAlternate J Clin Transl Hepatol
PublicationTitle_FL Journal of Clinical and Translational Hepatology
PublicationYear 2018
Publisher Gastroenterology and Liver Units, Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel
XIA & HE Publishing Inc
Publisher_xml – name: Gastroenterology and Liver Units, Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel
– name: XIA & HE Publishing Inc
References Sun (key20181105025923_b9) 2012; 30
Shahaf (key20181105025923_b5) 2011; 17
Khoury (key20181105025923_b22) 2015; 21
Zigmond (key20181105025923_b23) 2014; 7
Hunt (key20181105025923_b2) 2012; 12
Kaner (key20181105025923_b35) 2015; 211
Koulmanda (key20181105025923_b32) 2012; 7
Lewis (key20181105025923_b6) 2008; 105
Elinav (key20181105025923_b25) 2006; 208
Mizrahi (key20181105025923_b27) 2009
Massaguer (key20181105025923_b14) 2002; 72
Larson (key20181105025923_b28) 2007; 11
Guttman (key20181105025923_b15) 2015; 179
Ozeri (key20181105025923_b33) 2012; 189
Ochayon (key20181105025923_b37) 2013; 4
Lalazar (key20181105025923_b26) 2015; 35
Ilan (key20181105025923_b24) 2013; 47
Greene (key20181105025923_b1) 2011; 5
Tawara (key20181105025923_b34) 2012; 109
Mizrahi (key20181105025923_b4) 2013; 140
Wree (key20181105025923_b17) 2013; 10
Chen (key20181105025923_b19) 2015; 63
Brodsky (key20181105025923_b30) 2007; 3
Sandström (key20181105025923_b36) 2008; 25
Ikeda (key20181105025923_b21) 2015; 22
Jedicke (key20181105025923_b11) 2014; 59
Margalit (key20181105025923_b13) 2005; 289
Barnes (key20181105025923_b7) 2011; 50
Karadagi (key20181105025923_b12) 2017; 12
Bergin (key20181105025923_b3) 2012; 60
Bashir (key20181105025923_b31) 1992; 88
Mota (key20181105025923_b8) 2014; 34
Brunetti (key20181105025923_b10) 2008; 26
Meli (key20181105025923_b16) 2014; 5
Weir (key20181105025923_b38) 2009; 9
McClain (key20181105025923_b29) 1999; 1
Brenner (key20181105025923_b18) 2013; 59
Stephens (key20181105025923_b20) 2014; 14
References_xml – volume: 105
  start-page: 16236
  year: 2008
  ident: key20181105025923_b6
  article-title: Alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0807627105
  contributor:
    fullname: Lewis
– volume: 34
  start-page: 553
  year: 2014
  ident: key20181105025923_b8
  article-title: Alpha 1-antitrypsin activity is markedly decreased in Wegener’s granulomatosis
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-013-2745-9
  contributor:
    fullname: Mota
– volume: 60
  start-page: 81
  year: 2012
  ident: key20181105025923_b3
  article-title: Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent
  publication-title: Arch Immunol Ther Exp (Warsz)
  doi: 10.1007/s00005-012-0162-5
  contributor:
    fullname: Bergin
– volume: 7
  start-page: e33254
  year: 2012
  ident: key20181105025923_b32
  article-title: The role of TNF-α in mice with type 1- and 2- diabetes
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0033254
  contributor:
    fullname: Koulmanda
– volume: 5
  start-page: 395
  year: 2011
  ident: key20181105025923_b1
  article-title: The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency
  publication-title: Expert Rev Respir Med
  doi: 10.1586/ers.11.20
  contributor:
    fullname: Greene
– volume: 59
  start-page: 583
  year: 2013
  ident: key20181105025923_b18
  article-title: Decoding cell death signals in liver inflammation
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2013.03.033
  contributor:
    fullname: Brenner
– volume: 208
  start-page: 74
  year: 2006
  ident: key20181105025923_b25
  article-title: Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels
  publication-title: J Pathol
  doi: 10.1002/path.1869
  contributor:
    fullname: Elinav
– volume: 5
  start-page: 177
  year: 2014
  ident: key20181105025923_b16
  article-title: Role of innate immune response in non-alcoholic Fatty liver disease: metabolic complications and therapeutic tools
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2014.00177
  contributor:
    fullname: Meli
– volume: 63
  start-page: 503
  year: 2015
  ident: key20181105025923_b19
  article-title: Drug-induced liver injury: Interactions between drug properties and host factors
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2015.04.016
  contributor:
    fullname: Chen
– volume: 1
  start-page: 42
  year: 1999
  ident: key20181105025923_b29
  article-title: Acetaminophen hepatotoxicity: An update
  publication-title: Curr Gastroenterol Rep
  doi: 10.1007/s11894-999-0086-3
  contributor:
    fullname: McClain
– volume: 88
  start-page: 543
  year: 1992
  ident: key20181105025923_b31
  article-title: Alpha-1 anti-trypsin and CD30 expression occur in parallel in activated T cells
  publication-title: Clin Exp Immunol
  doi: 10.1111/j.1365-2249.1992.tb06484.x
  contributor:
    fullname: Bashir
– volume: 30
  start-page: 39
  year: 2012
  ident: key20181105025923_b9
  article-title: Increased expression of alpha 1-anti-trypsin in the synovial tissues of patients with ankylosing spondylitis
  publication-title: Clin Exp Rheumatol
  contributor:
    fullname: Sun
– volume: 12
  start-page: 827
  year: 2012
  ident: key20181105025923_b2
  article-title: Alpha 1 anti-trypsin: one protein, many functions
  publication-title: Curr Mol Med
  doi: 10.2174/156652412801318755
  contributor:
    fullname: Hunt
– start-page: 50
  year: 2009
  ident: key20181105025923_b27
  article-title: Suppression of NKT lymphocytes and TNF-Alpha and increased glutathione by β-glycosphingolipid protects against acetaminophen-induced liver injury. The American Association for the Study of Liver Diseases, The Liver Meeting, Boston
  publication-title: Abstract in Hepatology
  contributor:
    fullname: Mizrahi
– volume: 25
  start-page: 1370
  year: 2008
  ident: key20181105025923_b36
  article-title: An association between Type 2 diabetes and alpha-antitrypsin deficiency
  publication-title: Diabet Med
  doi: 10.1111/j.1464-5491.2008.02584.x
  contributor:
    fullname: Sandström
– volume: 47
  start-page: 298
  year: 2013
  ident: key20181105025923_b24
  article-title: Immune therapy for nonalcoholic steatohepatitis: are we there yet?
  publication-title: J Clin Gastroenterol
  doi: 10.1097/MCG.0b013e31827873dc
  contributor:
    fullname: Ilan
– volume: 50
  start-page: 1373
  year: 2011
  ident: key20181105025923_b7
  article-title: Relative α-1-anti-trypsin deficiency in systemic sclerosis
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/ker123
  contributor:
    fullname: Barnes
– volume: 22
  start-page: 528
  year: 2015
  ident: key20181105025923_b21
  article-title: Idiosyncratic drug hepatotoxicity: strategy for prevention and proposed mechanism
  publication-title: Curr Med Chem
  doi: 10.2174/0929867321666140916122628
  contributor:
    fullname: Ikeda
– volume: 3
  start-page: 623
  year: 2007
  ident: key20181105025923_b30
  article-title: Tipping the delicate balance: defining how proteasome maturation affects the degradation of a substrate for autophagy and endoplasmic reticulum associated degradation (ERAD)
  publication-title: Autophagy
  doi: 10.4161/auto.4906
  contributor:
    fullname: Brodsky
– volume: 17
  start-page: 1000
  year: 2011
  ident: key20181105025923_b5
  article-title: α-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection
  publication-title: Mol Med
  doi: 10.2119/molmed.2011.00145
  contributor:
    fullname: Shahaf
– volume: 10
  start-page: 627
  year: 2013
  ident: key20181105025923_b17
  article-title: From NAFLD to NASH to cirrhosis-new insights into disease mechanisms
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2013.149
  contributor:
    fullname: Wree
– volume: 11
  start-page: 525
  year: 2007
  ident: key20181105025923_b28
  article-title: Acetaminophen hepatotoxicity
  publication-title: Clin Liver Dis
  doi: 10.1016/j.cld.2007.06.006
  contributor:
    fullname: Larson
– volume: 59
  start-page: 2299
  year: 2014
  ident: key20181105025923_b11
  article-title: α -1-antitrypsin inhibits acute liver failure in mice
  publication-title: Hepatology
  doi: 10.1002/hep.27024
  contributor:
    fullname: Jedicke
– volume: 7
  start-page: 151
  year: 2014
  ident: key20181105025923_b23
  article-title: β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model
  publication-title: J Inflamm Res
  contributor:
    fullname: Zigmond
– volume: 140
  start-page: 362
  year: 2013
  ident: key20181105025923_b4
  article-title: Human α1-antitrypsin modifies B-lymphocyte responses during allograft transplantation
  publication-title: Immunology
  doi: 10.1111/imm.12149
  contributor:
    fullname: Mizrahi
– volume: 35
  start-page: 399
  year: 2015
  ident: key20181105025923_b26
  article-title: Oral administration of OKT3 MAb to patients with NASH, promotes regulatory T-cell induction, and alleviates insulin resistance: Results of a phase IIa blinded placebo-controlled trial
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-015-0160-6
  contributor:
    fullname: Lalazar
– volume: 72
  start-page: 262
  year: 2002
  ident: key20181105025923_b14
  article-title: Concanavalin-A-induced liver injury is severely impaired in mice deficient in P-selectin
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.72.2.262
  contributor:
    fullname: Massaguer
– volume: 189
  start-page: 146
  year: 2012
  ident: key20181105025923_b33
  article-title: α-1 antitrypsin promotes semimature, IL-10-producing and readily migrating tolerogenic dendritic cells
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1101340
  contributor:
    fullname: Ozeri
– volume: 14
  start-page: 286
  year: 2014
  ident: key20181105025923_b20
  article-title: Mechanisms of drug-induced liver injury
  publication-title: Curr Opin Allergy Clin Immunol
  doi: 10.1097/ACI.0000000000000070
  contributor:
    fullname: Stephens
– volume: 4
  start-page: 320
  year: 2013
  ident: key20181105025923_b37
  article-title: Human α1-antitrypsin binds to heat-shock protein gp96 and protects from endogenous gp96-mediated injury in vivo
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2013.00320
  contributor:
    fullname: Ochayon
– volume: 9
  start-page: 100
  year: 2009
  ident: key20181105025923_b38
  article-title: Control of inflammation with alpha1-antitrypsin: a potential treatment for islet transplantation and new-onset type 1 diabetes
  publication-title: Curr Diab Rep
  doi: 10.1007/s11892-009-0018-5
  contributor:
    fullname: Weir
– volume: 179
  start-page: 161
  year: 2015
  ident: key20181105025923_b15
  article-title: Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats
  publication-title: Clin Exp Immunol
  doi: 10.1111/cei.12476
  contributor:
    fullname: Guttman
– volume: 109
  start-page: 564
  year: 2012
  ident: key20181105025923_b34
  article-title: Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1117665109
  contributor:
    fullname: Tawara
– volume: 12
  start-page: e0177279
  year: 2017
  ident: key20181105025923_b12
  article-title: Exogenous alpha 1-antitrypsin down-regulates SERPINA1 expression
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0177279
  contributor:
    fullname: Karadagi
– volume: 26
  start-page: 196
  year: 2008
  ident: key20181105025923_b10
  article-title: Acute phase proteins and systolic dysfunction in subjects with acute myocardial infarction
  publication-title: J Thromb Thrombolysis
  doi: 10.1007/s11239-007-0088-7
  contributor:
    fullname: Brunetti
– volume: 21
  start-page: 7443
  year: 2015
  ident: key20181105025923_b22
  article-title: Altered distribution of regulatory lymphocytes by oral administration of soy-extracts exerts a hepatoprotective effect alleviating immune mediated liver injury, non-alcoholic steatohepatitis and insulin resistance
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v21.i24.7443
  contributor:
    fullname: Khoury
– volume: 289
  start-page: G917
  year: 2005
  ident: key20181105025923_b13
  article-title: Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes
  publication-title: Am J Physiol Gastrointest Liver Physiol
  doi: 10.1152/ajpgi.00105.2005
  contributor:
    fullname: Margalit
– volume: 211
  start-page: 1489
  year: 2015
  ident: key20181105025923_b35
  article-title: Acute phase protein α1-antitrypsin reduces the bacterial burden in mice by selective modulation of innate cell responses
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jiu620
  contributor:
    fullname: Kaner
SSID ssj0001510690
Score 2.117708
Snippet The serine proteinase inhibitor alpha-1 anti-trypsin (AAT) protects the body against protease activity. Several functions of AAT beyond those attributed to its...
Background and Aims:The serine proteinase inhibitor alpha-1 anti-trypsin (AAT) protects the body against protease activity.Several functions of AAT beyond...
Background and Aims: The serine proteinase inhibitor alpha-1 anti-trypsin (AAT) protects the body against protease activity. Several functions of AAT beyond...
SourceID pubmedcentral
wanfang
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 345
SubjectTerms Original
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LSwMxEA4-ELyI4qu-iKAHD9F9ZB85iBSp1KKeLPQWstlEK5pqu6Ltr3emu60WPXhb2GxYMpOZ7yMzXwg5sjqyoUg9pg0HgqKygAkdChajtp31uc09bBS-vYubbd7qRJ3v9uhqAQd_Uju8T6rdfz79fBtewIY_xw3PIUWdtS7vm1ilhWWR4LTzZDHgwNOxkK8C-2XPsI-yvHjbHDgxdu6I6tzyr0lm89Qv8Pm7hnLpQzmr3MOP9HS1SlYqXEnrpSOskTnj1smwjp20zKd1V3RZ0R--DrqONj5NvxhQRZuQiopepdQAUY-WUsa05-g1to0YNu4rAUxaDkX5I6pcTuvaFOql61CTwDFg9eAfOb3BEg967Z7ATBukfdW4v2yy6q4FpmGpChZ5KjFRooVvlcgDPwQaoZRJueBZmKtEpVmepJ6wXGcWUKUJPA2hMfVikxgb-eEmWXA9Z7YJjb0UQKVB3ZiMJxEEANSw14lRwgL8tDVyMllZ-VpKakikImgFiVaQaAU5tkKNHE6WXoLf42GGcqb3PpABRhbAbkFQI1ulKaazAQ0KgdnC18mMkaYDUFN79o3rPo61teMQKGQY1chxZU45cUn5rIejx4dsNJIGfxCjn7_zz3G7ZBmfsQ4mSPfIQtF_N_uAZorsYOykXxPC82k
  priority: 102
  providerName: Scholars Portal
Title Alpha-1 Anti-trypsin Exerts a Hepatoprotective Effect on Immune-mediated Hepatitis and Acetaminophen-induced Liver Injury
URI https://www.ncbi.nlm.nih.gov/pubmed/30637210
https://search.proquest.com/docview/2179362322
https://d.wanfangdata.com.cn/periodical/lcyzhgbzz-e201804001
https://pubmed.ncbi.nlm.nih.gov/PMC6328735
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxsxEB7iQEsupaWv7SOo0B56ULy70r6OxiQ4oS49JJCb0GqlZEssG3tDa__6zuwjxOTW8wqt0Dea-QbNfAL46kziRJGH3FiJCYouY14YUfCUtO1cJF0VUqPw_Gc6u5IX18n1ASRDL0xbtG_K-sTfLU58fdvWVq4WZjzUiY1_zaepQJ4vkvEIRmigj1L0rjU4IvVdelQObZUadIr-elJiOBtfTC9nVNFFJZRo4EfwHEmzwDwo3I9MT-jm06rJZ3-0d9rfPApIZy_hRc8k2aRb8Ss4sP41bCfUO8sjNvFNzZv1drWpPTv9a9fNhmk2w-DTLHttBvRzrBMvZkvPzqlRxPK2kwRZaDeUBI-Y9hWbGNvoRe1JhcBzzOPRIir2g4o62Ln_jcC8gauz08vpjPevK3AjhWh4EurMJpkpIqeLKo4EJg5a21wWshSVznReVlkeFk6a0iGPtHFo0BnmYWoz65JIvIVDv_T2PbA0zJFGWlKKKWWW4JEn1XqTWV04JJwugO_DzqpVJ6KhKPkgQBQBoggQ1QISwJdh6xVaOl1faG-X9xsVky9BthbHAbzroHiYbcAwgGwPpIcBpKK9_wWNq1XT7o0pgG89nKo_xRt1Z7a725tyt1OWFkj-Lvrw33_4CEc0C9XCxPknOGzW9_YzMpqmPIbRXObHrR3_A9Wz9pQ
link.rule.ids 230,315,730,783,787,888,2228,24330,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6VIqAXHoJS81wkOHDYxPb6eYyiVk5JKg4p6m21Xu-2hmYTJY5K8uuZ8aNq6AnOa_mhb3bmG_mbbwn5bFRoeJq4TOkAGhSZ-yxVPGURetsZLzCFi4PCk7MoOw9OL8KLPRJ2szC1aF_lZc9ez3q2vKq1lYuZ6nc6sf73yTDiwPN52H9AHsJ-dYM7TXozHOyh_y4eKwfRiiM6afuDMoCC1j8dTjPUdKGIEkL8gDwG2syhE3J3a9M9wnlfN_noRloj7eWdknTyjPzoPqZRovzqrau8p7Z_-Tz-89c-J09bkkoHzfILsqftS7IZ4Fgu8-jAViWrlpvFqrT0-LdeVisqaQZ1rZq3tg-QQmnji0znlo5wBkWzekgFCG5zKXopUWkLOlC6krPSosGBZaUtINgKOka9CB3Zn4D5K3J-cjwdZqw9uIGpgPOKha6MdRir1DMyLXyPQ08ipU6CNMh5IWOZ5EWcuKkJVG6AomrfVZBnEzfSsTahxw_Jvp1bfURo5CbAUDWa0ORBHEI2QUN8FWuZGuCyxiFfO8jEovHnENjXINICkRaItKiRdsinDlMBmwj_jEir5-uV8DFNARH0fYe8bjC-vVsXHA6Jd9C_vQANundXAMnaqLtFziFf2jgRbYJYiWu12V5d5tut0PiCmEq9N__9hI_kSTadjMV4dPbtLTnAO6Lkxk_ekf1qudbvgThV-Yd6m_wBjukXwQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELagiKoXCuK1UIqR4MDB2Yf3eYxCo6S0VQ-tVHGxvF67XWicKNkIkl_PzD6qpL31vNbuWt94_I38zWdCvhoVGZ6lHlM6hAJF5gHLFM9YjN52xg9N4WGj8OlZPLoMj6-iq42rvmrRvsrLnr2d9Gx5U2srZxPldjox9_x0EHPg-TxyZ4Vxn5JnsGa9eKNQbxqEffTgxavlIGKxTSdrDylD2NTc48HFCHVdKKSEMN8ju0CdOVRD3vb-9IB0PtROPv8rrZH2emNbGu6TX92EGjXKn96yyntqfc_r8VEzfkletGSV9pshr8gTbV-TVR_bc5lP-7YqWTVfzRalpUf_9LxaUElHsL9V09b-AVIpbfyR6dTSMfaiaFY3qwDRbYaipxKVtqB9pSs5KS0aHVhW2gKCrqAnqBuhY_sbsH9DLodHF4MRay9wYCrkvGKRJxMdJSrzjcyKwOdQm0ip0zALc17IRKZ5kaReZkKVG6CqOvAU5FtAUyfaRD5_S3bs1Or3hMZeCkxVoxlNHiYRZBU0xleJlpkBTmsc8r2DTcwanw6B9Q2iLRBtgWiLGm2HfOlwFbCY8IREWj1dLkSA6QoIYRA45F2D893bugBxSLIVAXcD0Kh7-wmgWRt2t-g55FsbK6JNFAtxq1brm-t8vRYafxBTqv_h0V_4THbPfwzFyfjs50eyhy9E5U2QHpCdar7Un4A_VflhvVL-A0soGkE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alpha-1+Anti-trypsin+Exerts+a+Hepatoprotective+Effect+on+Immune-mediated+Hepatitis+and+Acetaminophen-induced+Liver+Injury&rft.jtitle=%E4%B8%B4%E5%BA%8A%E4%B8%8E%E8%BD%AC%E5%8C%96%E8%82%9D%E7%97%85%E6%9D%82%E5%BF%97%EF%BC%88%E8%8B%B1%E6%96%87%E7%89%88%EF%BC%89&rft.au=Yehudit+Shabat&rft.au=Ami+Ben+Ya%27acov&rft.au=Yaron+Ilan&rft.date=2018-12-28&rft.pub=Gastroenterology+and+Liver+Units%2C+Department+of+Medicine%2C+Hebrew+University-Hadassah+Medical+Center%2C+Jerusalem%2C+Israel&rft.issn=2225-0719&rft.volume=6&rft.issue=4&rft.spage=345&rft.epage=349&rft_id=info:doi/10.14218%2FJCTH.2018.00030&rft.externalDocID=lcyzhgbzz_e201804001
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Flcyzhgbzz-e%2Flcyzhgbzz-e.jpg